Introduction. The transformation of higher medical education, caused by the rapid development of medical technologies and growing social demands on the healthcare system, requires research into students’ ideas about quality education, their assessments and expectations, since students’ understanding of the learning process can have a significant impact on the development of student motivation and medical professionalism. The purpose of the study is to analyze the current system of higher medical education in the Russian Federation based on survey data from senior students, residents, and practicing doctors. Materials and methods. The survey involved 350 respondents (senior students, residents, practicing physicians) mainly from Moscow medical higher education institutions. Statistical analysis was carried out using the software StatTech v. 3.0.4. Methods of mathematical statistics: U-Mann-Whitney, Kruskal-Wallis, χ2 -Pearson tests. Results. It was revealed that only 52% of respondents consider the amount of theoretical knowledge acquired at a higher education institution under a specialty program to be sufficient. Students and graduates of the pediatric faculty more often consider the amount of theoretical training sufficient compared to respondents from the medical and dental faculties (p < 0.001). Only half of the respondents are satisfied with the quality of the education received. Students and graduates of the Faculty of Pediatrics more often stated that they use the knowledge and skills acquired during practical training in their professional activities (p < 0.001). Students and graduates of medical faculties of non-core Moscow universities and Russian National Research Medical University named after N.I. Pirogov are most satisfied with the amount of theoretical knowledge received within the framework of the specialty program compared to students and graduates of other higher education institutions (p < 0.001). Conclusion. The results of this study may be valuable for government agencies that determine strategies for the development of higher medical education in Russia, as well as for university leaders who plan targets for the development of educational activities with an emphasis on involving students in the educational process.
10 August 2023 in Pediatria. Journal named after G.N. Speransky
MHMoscow Moscow City Center For Pediatric Rheumatology With The Morozov Children’s City Clinical Hospital
Moscow Moscow City Center For Pediatric Rheumatology With The Morozov Children’s City Clinical Hospital
+2
The problem of the survival of various genetically engineered biological drugs (GEBD) is of a current scientific interest. A clear analysis of the reasons for the withdrawal coupled with the GEBD switching algorithmizing would allow developing of the individual treatment plans and monitoring of the patients. The objective of the study was to analyze the survival of genetically engineered biological therapy in children with juvenile idiopathic arthritis (JIA) through identifying the frequency and structure of cases of switching/cancellation of GEBD. Materials and methods: based on the data obtained from the Moscow registry of children with rheumatic diseases, an observational analytical cross-sectional study was conducted, including patients with JIA aged 0 to 17 years old living in Moscow, who had a history of episodes of switching or cancellation of GEBD. The study was conducted from January, 2015 to December, 2021. Results: 1220 patients (35.8% male/64.2% female) with JIA were included in the study. The median age of patients was 11.0 (8.0; 15.0) years. The total number of prescribing of GEBD of the first and subsequent lines was 589 episodes in 531 patients, of which 46 patients had 64 episodes of switching or cancellation of GEBD, which accounted for 10.9% of all cases of prescribing of GEBD. In the structure of the reasons for the therapy change the secondary failure accounted for 57.8%, the primary failure - 12.5%, intolerance - 10.9%, de novo uveitis - 9.4%. Cancellation of the drug therapy due to the achievement of remission was noted in 6.2% of cases. There are statistically significant differences in the duration of therapy depending on the reason for discontinuation or replacement of therapy (p<0.001). More often, patients were transferred to adalimumab (29.3%), and when adalimumab was canceled, to tocilizumab and golimumab. In the event of tocilizumab discontinuation, the majority of patients were switched to canakinumab drug therapy. Conclusion: the presented analysis is one of a few studies of such kind that were ever conducted in Russia; it requires further accumulation and analysis of data, including cases of discontinuation of the drug therapy, switching between the drugs, as well as the duration of therapy before the event that caused the change or discontinuation of the drug therapy happened.
Vitamin D deficiency in children is associated with muscle weakness, arthralgia, and nonspecific growing pains. Low serum 25(OH)D concentration is associated with an increased risk of autoimmune rheumatic diseases, including juvenile idiopathic arthritis. The high prevalence of vitamin D deficiency and insufficiency in the Russian pediatric population underscores the need for its assessment to identify risk factors for joint pathology. Objective. To assess the prevalence and structure of vitamin D deficiency (severe deficiency, deficiency, insufficiency) in children with arthralgia across different age groups based on a retrospective analysis. Patients and methods. A retrospective observational cross-sectional study was conducted based on the analysis of medical records of 264 patients aged 1–17 years who consulted a rheumatologist with complaints of joint pain. Serum 25(OH)D concentration was measured by high-performance liquid chromatography with tandem mass spectrometric detection. Statistical analysis included the Kruskal–Wallis test and Fisher's exact test. Results. Normal 25(OH)D concentration (≥30 ng/mL) was found in only 28.4% of patients, severe deficiency (<10 ng/mL) – in 9.1%, deficiency (10–19.9 ng/mL) – in 33.3%, insufficiency (20–29.9 ng/mL) – in 29.2%. No statistically significant differences by sex were found (p = 0.886). The proportion of children with normal vitamin D concentration decreased with age: in the 1–6 years group it was 45.2% (14/31), in the 7–11 years group – 33.3% (30/90), and in the 12–17 years group – 22.4% (32/143). When comparing proportions using Fisher's exact test, differences between the 1–6 years and 12–17 years groups, as well as between the 7–11 years and 12–17 years groups, were statistically significant (p = 0.013 and p = 0.030, respectively). The overall difference across the three age groups was also confirmed (p = 0.014). Conclusion. A reduced serum 25(OH)D concentration was found in the majority of children with arthralgia. The lowest vitamin D status was observed in the 12–17 years age group. The results justify the need to strengthen the prevention of vitamin D deficiency, especially in children older than 7 years. Key words: vitamin D, vitamin D deficiency, children, growing pains, arthralgia